1. [P168] Volumetric modulated arc therapy using multi-criteria dose plan optimization for anal cancer – Feasibility of selective sparing of organs at risk. (August 2018) Authors: Rønde, Heidi S.; Wee, Leonard; Bokrantz, Rasmus; Pløen, John; Appelt, Ane L. Journal: Physica medica Issue: Volume 52(2018)Supplement 1 Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A 3-weekly schedule of irinotecan and panitumumab for wild-type KRAS metastatic colorectal cancer. (April 2014) Authors: Hansen, Torben Frøstrup; Andersen, Rikke Fredslund; Pallisgaard, Niels; Spindler, Karen-Lise Garm; Pløen, John; Keldsen, Nina; Lindebjerg, Jan; Sørensen, Flemming Brandt; Jakobsen, Anders Journal: Colorectal cancer Issue: Volume 3:Number 2(2014) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Feasibility of preference-driven radiotherapy dose treatment planning to support shared decision making in anal cancer. (3rd October 2017) Authors: Rønde, Heidi S.; Wee, Leonard; Pløen, John; Appelt, Ane L. Journal: Acta oncologica Issue: Volume 56:Number 10(2017) Page Start: 1277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Issue 8 (August 2015) Authors: Appelt, Ane L; Pløen, John; Harling, Henrik; Jensen, Frank S; Jensen, Lars H; Jørgensen, Jens C R; Lindebjerg, Jan; Rafaelsen, Søren R; Jakobsen, Anders Journal: Lancet oncology Issue: Volume 16:Issue 8(2015:Aug.) Page Start: 919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Issue 8 (August 2015) Authors: Appelt, Ane L; Pløen, John; Harling, Henrik; Jensen, Frank S; Jensen, Lars H; Jørgensen, Jens C R; Lindebjerg, Jan; Rafaelsen, Søren R; Jakobsen, Anders Journal: Lancet oncology Issue: Volume 16:Issue 8(2015:Aug.) Page Start: 919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immunohistological expression of HIF‐1α, GLUT‐1, Bcl‐2 and Ki‐67 in consecutive biopsies during chemoradiotherapy in patients with rectal cancer. Issue 2 (17th August 2012) Authors: Havelund, Birgitte Mayland; Sørensen, Flemming Brandt; Pløen, John; Lindebjerg, Jan; Spindler, Karen‐Lise Garm; Jakobsen, Anders Journal: Apmis Issue: Volume 121:Issue 2(2013:Feb.) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial. (26th November 2015) Authors: Jakobsen, Anders; Andersen, Fahimeh; Fischer, Anders; Jensen, Lars H.; Jørgensen, Jens C. R.; Larsen, Ole; Lindebjerg, Jan; Pløen, John; Rafaelsen, Søren R.; Vilandt, Jesper Journal: Acta oncologica Issue: Volume 54:Number 10(2015) Page Start: 1747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan. (February 2014) Authors: Nørgaard, Anne; Dam, Claus; Jakobsen, Anders; Pløen, John; Lindebjerg, Jan; Rafaelsen, Søren R. Journal: Scandinavian journal of gastroenterology Issue: Volume 49:Number 2(2014) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗